Labs and Centers

Cell and Gene Therapy - Goldman Lab

The Goldman Lab of the Center for Translational Neuromedicine focuses on the following projects:

Center for Neural Development and Disease (CNDD)

The Center for Neural Development and Disease (CNDD) at the University of Rochester Medical Center brings together faculty from diverse departments, including Neurology, Pediatrics, Biomedical Genetics, Biochemistry and Biophysics, Opthalmology, Emergency Medicine, and Neurobiology and Anatomy, to carry out research directed toward understanding how genes and environment build the human brain and modulate its function in health and disease

Clinical Trials Coordination Center (CTCC)

A research unit of the University of Rochester’s Department of Neurology, operates to foster multi-institutional academic research through the development, management, and reporting of hypothesis-driven, controlled clinical trials.

Fields Center for FSHD & Neuromuscular Research

The Fields Center for FSHD and Neuromuscular Research represents the first concerted international effort to accelerate aggressive and innovative clinical and genetic research to find treatments for people with facioscapulohumeral muscular dystrophy (FSHD).

MSG (Muscle Study Group)

The Muscle Study Group (MSG), is a consortium of scientific investigators from academic and research centers who are committed to the cooperative planning, implementation, analysis and reporting of controlled clinical trials and of other research for muscle and other neuromuscular diseases.

Muscular Dystrophy Cooperative Research Center

As nationally recognized centers of excellence in muscular dystrophy, the Senator Paul D. Wellstone MDCRCs were charged with the task of establishing research programs focused on major questions about muscular dystrophy.

National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members

National Registry was developed to: 1) Help people with Myotonic Dystrophy (DM) or Facioscapulohumeral Muscular Dystrophy (FSHD) participate in research on their disease. 2) Help investigators accomplish their research by connecting them with people who have DM or FSHD. 3) Encourage more research on these rare diseases.

Study of Antidepressants in Parkinsons Disease (SADPD)

The University of Rochester is conducting a research study of antidepressant medication in patients with Parkinson’s disease (PD) at several medical centers throughout the United States and Canada.